Equities

Sundrug Co Ltd

Sundrug Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)3,555.00
  • Today's Change115.00 / 3.34%
  • Shares traded656.40k
  • 1 Year change-19.24%
  • Beta0.4289
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Sundrug Co Ltd grew revenues 8.88% from 690.46bn to 751.78bn while net income improved 13.32% from 25.70bn to 29.13bn.
Gross margin25.27%
Net profit margin3.78%
Operating margin5.30%
Return on assets7.43%
Return on equity11.61%
Return on investment10.49%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Sundrug Co Ltd fell by 11.17bn. However, the company earned 41.19bn from its operations for a Cash Flow Margin of 5.48%. In addition the company generated 22.49bn cash from financing while 74.85bn was spent on investing.
Cash flow per share390.44
Price/Cash flow per share8.99
Book value per share2,229.34
Tangible book value per share2,153.59
More ▼

Balance sheet in JPYView more

Sundrug Co Ltd has a Debt to Total Capital ratio of 11.66%.
Current ratio1.74
Quick ratio0.9398
Total debt/total equity0.132
Total debt/total capital0.1166
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 14.00% and 13.31%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Grocery) industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.25%
Div growth rate (5 year)11.55%
Payout ratio (TTM)48.63%
EPS growth(5 years)4.00
EPS (TTM) vs
TTM 1 year ago
8.52
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.